Literature DB >> 23864673

Disassociation of histone deacetylase-3 from normal huntingtin underlies mutant huntingtin neurotoxicity.

Farah H Bardai1, Pragya Verma, Chad Smith, Varun Rawat, Lulu Wang, Santosh R D'Mello.   

Abstract

Huntington's disease (HD) is caused by a polyglutamine expansion within the huntingtin (Htt) protein. Both loss of function of normal Htt and gain of a toxic function by the polyglutamine-expanded mutant Htt protein have been proposed to be responsible for HD, although the molecular mechanisms involved are unclear. We show that Htt is a neuroprotective protein in both HD-related and unrelated model systems. Neuroprotection by Htt is mediated by its sequestration of histone deacetylase-3 (HDAC3), a protein known to promote neuronal death. In contrast to the normal Htt, mutant Htt interacts poorly with HDAC3. However, expression of mutant Htt liberates HDAC3 from Htt, thus de-repressing its neurotoxic activity. Indeed, mutant Htt neurotoxicity is inhibited by the knockdown of HDAC3 and markedly reduced in HDAC3-deficient neurons. A reduction in Htt-HDAC3 interaction is also seen in neurons exposed to other apoptotic stimuli and in the striatum of R6/2 HD mice. Our results suggest that the robust interaction between Htt and HDAC3 along with the ability of mutant Htt to disrupt this association while not itself interacting with HDAC3 provides an explanation for both the loss-of-function and gain-of-toxic-function mechanisms proposed for HD. Moreover, our results identify HDAC3 as an essential player in mutant Htt-induced neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23864673      PMCID: PMC3713725          DOI: 10.1523/JNEUROSCI.5831-12.2013

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  29 in total

1.  Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease.

Authors:  L W Ho; R Brown; M Maxwell; A Wyttenbach; D C Rubinsztein
Journal:  J Med Genet       Date:  2001-07       Impact factor: 6.318

2.  Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo.

Authors:  B R Leavitt; J A Guttman; J G Hodgson; G H Kimel; R Singaraja; A W Vogl; M R Hayden
Journal:  Am J Hum Genet       Date:  2000-12-20       Impact factor: 11.025

3.  Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice.

Authors:  I Dragatsis; M S Levine; S Zeitlin
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

4.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.

Authors:  J S Steffan; L Bodai; J Pallos; M Poelman; A McCampbell; B L Apostol; A Kazantsev; E Schmidt; Y Z Zhu; M Greenwald; R Kurokawa; D E Housman; G R Jackson; J L Marsh; L M Thompson
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

5.  Histone deacetylase-1 (HDAC1) is a molecular switch between neuronal survival and death.

Authors:  Farah H Bardai; Valerie Price; Marcus Zaayman; Lulu Wang; Santosh R D'Mello
Journal:  J Biol Chem       Date:  2012-08-23       Impact factor: 5.157

6.  Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation.

Authors:  Jenny Carmichael; Katherine L Sugars; Yi Ping Bao; David C Rubinsztein
Journal:  J Biol Chem       Date:  2002-07-03       Impact factor: 5.157

7.  The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.

Authors:  Sandrine Humbert; Elzbieta A Bryson; Fabrice P Cordelières; Nathan C Connors; Sandeep R Datta; Steven Finkbeiner; Michael E Greenberg; Frédéric Saudou
Journal:  Dev Cell       Date:  2002-06       Impact factor: 12.270

8.  Wild-type huntingtin protects from apoptosis upstream of caspase-3.

Authors:  D Rigamonti; J H Bauer; C De-Fraja; L Conti; S Sipione; C Sciorati; E Clementi; A Hackam; M R Hayden; Y Li; J K Cooper; C A Ross; S Govoni; C Vincenz; E Cattaneo
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

9.  Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.

Authors:  C Zuccato; A Ciammola; D Rigamonti; B R Leavitt; D Goffredo; L Conti; M E MacDonald; R M Friedlander; V Silani; M R Hayden; T Timmusk; S Sipione; E Cattaneo
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728

10.  Depletion of wild-type huntingtin in mouse models of neurologic diseases.

Authors:  Yu Zhang; Mingwei Li; Martin Drozda; Minghua Chen; Shengjun Ren; Rene O Mejia Sanchez; Blair R Leavitt; Elena Cattaneo; Robert J Ferrante; Michael R Hayden; Robert M Friedlander
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

View more
  29 in total

1.  Cell and Context-Dependent Effects of the Heat Shock Protein DNAJB6 on Neuronal Survival.

Authors:  Chad Smith; Santosh R D'Mello
Journal:  Mol Neurobiol       Date:  2015-10-17       Impact factor: 5.590

2.  Increased Olfactory Bulb BDNF Expression Does Not Rescue Deficits in Olfactory Neurogenesis in the Huntington's Disease R6/2 Mouse.

Authors:  Shamayra Smail; Dalbir Bahga; Brittnee McDole; Kathleen Guthrie
Journal:  Chem Senses       Date:  2016-01-18       Impact factor: 3.160

3.  Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition.

Authors:  Sama F Sleiman; David E Olson; Megan W Bourassa; Saravanan S Karuppagounder; Yan-Ling Zhang; Jennifer Gale; Florence F Wagner; Manuela Basso; Giovanni Coppola; John T Pinto; Edward B Holson; Rajiv R Ratan
Journal:  J Neurosci       Date:  2014-10-22       Impact factor: 6.167

4.  Histone deacetylase 3 is necessary for proper brain development.

Authors:  Jordan Norwood; Jade M Franklin; Dharmendra Sharma; Santosh R D'Mello
Journal:  J Biol Chem       Date:  2014-10-22       Impact factor: 5.157

Review 5.  Complex neuroprotective and neurotoxic effects of histone deacetylases.

Authors:  Elizabeth A Thomas; Santosh R D'Mello
Journal:  J Neurochem       Date:  2018-04-06       Impact factor: 5.372

6.  Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

Authors:  Anto Sam Crosslee Louis Sam Titus; Tanzeen Yusuff; Marlène Cassar; Elizabeth Thomas; Doris Kretzschmar; Santosh R D'Mello
Journal:  J Neurosci       Date:  2017-05-26       Impact factor: 6.167

7.  Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury.

Authors:  Heather M Schmitt; Cassandra L Schlamp; Robert W Nickells
Journal:  J Ocul Pharmacol Ther       Date:  2017-12-06       Impact factor: 2.671

8.  The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1.

Authors:  Anand Venkatraman; Yuan-Shih Hu; Alessandro Didonna; Marija Cvetanovic; Aleksandar Krbanjevic; Patrice Bilesimo; Puneet Opal
Journal:  Hum Mol Genet       Date:  2014-03-04       Impact factor: 6.150

9.  HSF1 protects neurons through a novel trimerization- and HSP-independent mechanism.

Authors:  Pragya Verma; Jason A Pfister; Sathi Mallick; Santosh R D'Mello
Journal:  J Neurosci       Date:  2014-01-29       Impact factor: 6.167

Review 10.  Histone deacetylase-3: Friend and foe of the brain.

Authors:  Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.